Aggramed 5mg Infusion
Aggramed 5mg Infusion is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. You should continue all your other medicines that are advised by the doctor for your long term treatment even after this injection.
Aggramed 5mg Infusion
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Aggramed 5mg Infusion is a blood thinner which prevents formation of harmful blood clots. It helps to prevent a heart attack in patients presenting with severe chest pain due to a sudden decrease in blood flow to the heart.
Aggramed 5mg Infusion is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. You should continue all your other medicines that are advised by the doctor for your long term treatment even after this injection.
Common side effects of this medicine include headaches, hematoma, nausea, ecchymosis, postoperative bleeding, and blood in stool or urine. Let your doctor know immediately if you see pinpoint rash or blood in your vomits, urine, or stool.
This medicine is used with caution for some people. Before taking it, you must inform the doctor if you are suffering from any bleeding disorder, kidney, or liver disease. Also, let your doctor know if you are breastfeeding and about all the other medications that you are taking regularly.
03Uses
Prevention of Heart attack
04How To Use
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
05How It Works
Aggramed 5mg Infusion is an antiplatelet medication. It works by preventing the platelets from sticking together, thereby decreasing the formation of harmful blood clots. This lowers the chance of heart attack or stroke.
06What If You Miss A Dose?
If you miss a dose of Aggramed 5mg Infusion, please consult your doctor.
07Benefits
In Prevention of Heart attack
It prevents blood from clotting inside the veins and arteries. This helps the blood flow freely around your body thereby preventing a heart attack or stroke (or deep vein thrombosis or pulmonary embolism). Follow your doctor’s instructions carefully and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.
08Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Blood in urine
Blood in stool
Postoperative bleeding
Ecchymosis (discoloration of the skin resulting from bleeding underneath)
Hematoma
Nausea
Headache
09Safety Information
Alcohol:CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Aggramed 5mg Infusion. Please consult your doctor.
Pregnancy:SAFE IF PRESCRIBED
Aggramed 5mg Infusion is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding:CAUTION
Aggramed 5mg Infusion should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving:NOT RELEVANT
Not relevant, as Aggramed 5mg Infusion is intended for use in hospitalised patients.
Kidney:CAUTION
Aggramed 5mg Infusion should be used with caution in patients with kidney disease. Dose adjustment of Aggramed 5mg Infusion may be needed. Please consult your doctor.
Liver:CAUTION
Aggramed 5mg Infusion should be used with caution in patients with liver disease. Dose adjustment of Aggramed 5mg Infusion may be needed. Please consult your doctor.Use of Aggramed 5mg Infusion is not recommended in patients with severe liver disease.
10Drug Tips
It increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails or using sharp objects.
Notify your doctor if you see blood in your vomit, urine or stool (black, tarry stools or bright red blood).
References
Sources and references
Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 871-72.
Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. p. 355.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1369-70.
Central Drugs Standard Control Organisation . view
Tirofiban hydrochloride monohydrate. Uxbridge, UK: Correvio UK Ltd.; 1999 . view
